Adaptive Biotechnologies vs GeneDx

Adaptive Biotechnologies vs GeneDx, compared side by side on 13 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Adaptive Biotechnologies is on 69/100 and GeneDx on 50/100.

Adaptive Biotechnologies logo
Adaptive BiotechnologiesLeveraging the adaptive immune system to diagnose and treat disease.
Try Adaptive Biotechnologies
GeneDx logo
GeneDxGeneDx is a leading provider of genomic testing and interpretation services for rare and common diseases.
Try GeneDx

Where each one leads

Adaptive Biotechnologies

  • our overall score: 69/100 against 50/100

GeneDx

  • funding raised: $550M against $300M

At a glance

MeasureAdaptive BiotechnologiesGeneDx
What it isLeveraging the adaptive immune system to diagnose and treat disease.GeneDx is a leading provider of genomic testing and interpretation services for rare and common diseases.
CategoryBiotech, HealthTech, Genomics, Drug DiscoveryGenomics, HealthTech, MedTech, Clinical Trials
Sells toBusiness modelB2BB2B
OfferingSoftware | services | platformServices
Founded20091997
HeadquartersSeattle, United StatesGaithersburg, United States
StatusActiveActive

Size, funding and growth

MeasureAdaptive BiotechnologiesGeneDx
EmployeesNot published1,257
Total funding$300M$550M
Latest roundSeries DNot published
LinkedIn followersNot published66,864

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureAdaptive BiotechnologiesGeneDx
StartupHub scoreOur 0-100 rating69/10050/100
TractionNot published40/100
CommunityNot published15/100
Search visibilityNot published2/100
Agent readinessHow well an AI agent can read and act on the siteF (39/100)D (41/100)
Domain ratingLink authority, 0-10062/10065/100

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureAdaptive BiotechnologiesGeneDx
HostingSelf ManagedNot detected
CDNNot detectedCloudflare
CMSWordPressWebflow
FrameworksJqueryNot detected
AnalyticsGoogle Tag ManagerGoogle Tag Manager

Adaptive Biotechnologies vs GeneDx: common questions

Which is better, Adaptive Biotechnologies or GeneDx?

On our 0-100 score Adaptive Biotechnologies rates higher (69/100 against 50/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 13 data points above: read the rows that match what you are buying for.

How do Adaptive Biotechnologies and GeneDx compare on the numbers?

Adaptive Biotechnologies leads on our overall score (69/100 against 50/100). GeneDx leads on funding raised ($550M against $300M).

Read the full Adaptive Biotechnologies review and pricing or the GeneDx review and pricing. You can also browse other Adaptive Biotechnologies alternatives we track.